RECORDS ARE PUBLISHED REGULATORY ACTIONS. FIELDS THE ISSUING AUTHORITY DID NOT PUBLISH ARE MARKED AS NOT STATED, NEVER FILLED IN.
Drug Eye AfricaNational Actions, Continental Reach
Register / Rwanda / DEA-RW-0000-16076249
Rwanda Food and Drugs Authority · Rwanda
DEA-RW-0000-16076249
Tier 1 · Regulator-publishedClass IRecallStatus · active
Issuing authority
Rwanda Food and Drugs Authority (RWANDAFDA)
Authority reference
Not stated by the issuing authority
Date issued
07 Oct 2021Taken from the "Date of Recall" cell. The column is day-first: 121 of its values have a first component above 12 and none have a second above 12, which settles the ambiguity this record was previously held open for.
Recorded by us
2026-09-06 18:40:27 UTC
Product
Colosar-Denk 50mg /12,5mg film coated tablet
INN / active substance
Not stated by the issuing authority
Dosage form
Not stated by the issuing authority
Strength
Not stated by the issuing authority
Manufacturer
DENK PHARMA
Manufacturer country
Not stated by the issuing authority
MAH or importer
Not stated by the issuing authority
Batch numbers
Not published with the notice
Expiry dates
Not published with the notice
Action type
Recall
Classification
Class I as issued
Indicative severity
Not assessed by Drug Eye Africa
Defect category
Impurity
Product type
Medicine
ATC code
Not stated by the issuing authority
Affected markets
Rwanda — no market beyond the issuing country was named on the notice
Cross-border event
Not linked to a cross-border event
Notice text
Genotoxic impurity detected in API
Original language: en
Status
Active
Superseded by
Not superseded. This is the current version.
Version
6

Provenance

Verification tier 1

Where this record came from, and what is held to show it.

Copy of the source
Taken and held by Drug Eye Africa, so the record survives the link above being moved or withdrawn. Not yet published at an address you can open.
Ask us for it and check it against the fingerprint below.
Fingerprint
caea2b6c82061d0f0d7544778912ecb9e3f778399227e273568f7e06e938a294
SHA-256 of the copy held. Any file that produces this number is that copy, byte for byte; any file that does not is a different document.
Copy taken
2026-09-09 10:03:33 UTC

Related actions elsewhere

Same stated defect
ReferenceDateCtryProductBatchesActionClassSource
DEA-RW-2024-8123105812 Apr 2024RWBenylin Pediatrics Syrup BN:329304, Mfd: May 2021,Exp:April 2024
Johnson & Johnson, South Africa
329304RecallClass ITier 1 · Regulator-published
DEA-RW-0000-8646825107 Oct 2021RWLosar-Denk 50 mg film Coated
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
DEA-RW-0000-5154791007 Oct 2021RWLosar-Denk 25 mg film Coated
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
DEA-RW-0000-4094337807 Oct 2021RWColosar-Denk 100 mg /12,5mg film coated tablet
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
DEA-RW-0000-2502079207 Oct 2021RWLosar-Denk 100 mg film Coated
DENK PHARMA
none publishedRecallClass ITier 1 · Regulator-published
Cite this record
Drug Eye Africa (2021). DEA-RW-0000-16076249: Colosar-Denk 50mg /12,5mg film coated tablet — Recall, Rwanda Food and Drugs Authority. Register of African Regulatory Actions. https://drugeyeafrica.org/register/notice/rw/2021/dea-rw-0000-16076249

Version history

No version history recorded for this record.
Corrections appear here and in the site-wide log. Records are superseded, never deleted.

Verification

Tier 1Published by the issuing regulator on its own channel and captured by Drug Eye Africa, with the source document archived.

Indexing

This record is indexable: it is dated, names a product, and carries either a batch number or a stated reason.